Skyscape Web Viewer : Targeted Cancer Therapy A Handbook for Nurses : Main Index

View All
Tumor necrosis factor α Monoclonal Antibodies Targeting Angiogenesis
Tumors, primary, formation of
Tumor Suppressor Genes Application Of The Hallmarks Of Cancer Chapter 2. Targeted Cancer Therapy: External and Internal Signaling Pathway Targets Dna Repair Gene Mutations: Opportunities From Synthetic Lethality Epigenetic Abnormalities (Dna Methyltransferase and Histone Deacetylase) Glossary Hypoxia-Inducible Factor, Mtor, and Angiogenesis Protein Kinase Signaling Pathways References
Tumor vasculature
Protein Kinase Inhibitors Protein Kinase Signaling Pathways
TWIST1
TWIST2
Tykerb,
Tykerb CARES enrollment form, completing
Tyrosine kinase domain activation, turning off HER family activity in cancer cells and
Tyrosine kinase inhibitors Antiangiogenic Drug Therapy Chapter 2. Targeted Cancer Therapy: External and Internal Signaling Pathway Targets Drug Interactions: Focus On The P450 Microenzyme System Glossary Hypoxia-Inducible Factor, Mtor, and Angiogenesis Intracellular Signaling Kinases (E.g., Src, P13k/Akt/Mtor; Mapk; Sonic Hedgehog Pathways) Membrane-Bound Receptor Kinases (E.g., Egfr, Her2, Hgf/C-Met, Igfr Pathways) Nursing Considerations and Drug Information Protein Kinase Inhibitors References (Chapter 2) References (Chapter 3)
Ubiquitin/proteasome pathway apoptosis control and Glossary interaction with NFkB and Introduction Mitotic Kinase Inhibitors Protein Dynamics: Heat Shock Proteins and Ubiquitin - Proteasome Inhibitors
Ubiquitin-proteasome inhibitors Protein Dynamics: Heat Shock Proteins and Ubiquitin - Proteasome Inhibitors Protein Kinase Inhibitors
Ubiquitin tagging Protein Dynamics: Heat Shock Proteins and Ubiquitin - Proteasome Inhibitors Protein Kinase Inhibitors
UGT1A1, sorafenib coadministered with
UGT1A1*28 genotype Drug Interactions: Focus On The P450 Microenzyme System Protein Kinase Inhibitors
Ultrarapid drug metabolism
uPA,
Upstream Application Of The Hallmarks Of Cancer Glossary Hypoxia-Inducible Factor, Mtor, and Angiogenesis Membrane-Bound Receptor Kinases (E.g., Egfr, Her2, Hgf/C-Met, Igfr Pathways) Protein Kinase Signaling Pathways
Urokinase plasminogen activator Invasion and Metastasis Targeting Angiogenesis
Vadimeza (Novartis) Antiangiogenic Drug Therapy Hypoxia-Inducible Factor, Mtor, and Angiogenesis
Vandetanib (D6474, Zactima, investigational) adverse reactions Antiangiogenic Drug Therapy class dosage, reconstitution, and administration mechanism of action Nursing Considerations and Drug Information
Vascular-disrupting agents Antiangiogenic Drug Therapy Chapter 2. Targeted Cancer Therapy: External and Internal Signaling Pathway Targets Hypoxia-Inducible Factor, Mtor, and Angiogenesis References (Chapter 3) Tumor Vasculature and Microenvironment
Vascular endothelial cells
Vascular endothelial growth factor Application Of The Hallmarks Of Cancer bevacizumab targets and Bone Metastasis Glossary inhibitors Invasion and Metastasis MAbs directed against neutralizing References (Chapter 3) signaling Targeting Angiogenesis
Vatalanib (PTK787/ZK222584, investigational) adverse reactions class dosage, reconstitution, and administration mechanism of action metabolism Nursing Considerations and Drug Information
VDAs,
Vectibix,
VEGF,
VEGF-A Antiangiogenic Drug Therapy Glossary Hypoxia-Inducible Factor, Mtor, and Angiogenesis Invasion and Metastasis Membrane-Bound Receptor Kinases (E.g., Egfr, Her2, Hgf/C-Met, Igfr Pathways) Nursing Considerations and Drug Information Protein Dynamics: Heat Shock Proteins and Ubiquitin - Proteasome Inhibitors Targeting Angiogenesis Tumor Vasculature and Microenvironment